Search

Search Constraints

You searched for: Author/Creator Mulenga, Veronica

Search Results

1. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Issue 2 (February 2016)

2. Anthropometric Measurements and Lipid Profiles to Detect Early Lipodystrophy in Antiretroviral Therapy Experienced HIV-Infected Children in the Chapas-3 Trial. Issue 3 (April 2014)

3. Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets. (24th April 2017)

4. Effect of systematic tuberculosis detection on mortality in young children with severe pneumonia in countries with high incidence of tuberculosis: a stepped-wedge cluster-randomised trial. Issue 3 (March 2023)

5. Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations. (22nd August 2021)

6. Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children. (1st October 2016)

7. The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children. (25th April 2016)